SCDTDP

Initiatives

Sickle Cell Disease Treatment Demonstration Program

We work with four regional teams from across the country to increase the number of providers treating persons for sickle cell disease or sickle cell related issues, increase the number of providers prescribing disease modifying therapies, such as hydroxyurea, and increase the number of patients receiving regular care from providers knowledgeable about treating sickle cell disease.

alt

Status: Active

September 2014 to September 2017

  • Who: Four regional grantee teams that cover diverse HRSA-designated regions across the country. Partnerships include sickle cell treatment centers, federally qualified health centers, community based organizations, parents and patients.
  • Funder: The project is funded by the Health Resources and Services Administration.
  • Our Role: Gather data from and evaluate the performance of SCDTDP grantees in addressing the goals of the program. Deliver a comprehensive report to congress that outlines results of the project, develop a model protocol that outlines strategies for improving sickle cell care, and establish a compendium of tools and materials developed by teams.

If you are interested in learning more about this project, email: SCDTDP2014-2017@nichq.org

Highlights

The following flyers were created for regional coordinating centers to use to talk about their involvement in the project and the project's impact:

ECHO flyer: This flyer shares information about the use of Project ECHO to expand the number of providers able to treat patients with sickle cell disease.

Impact Flyer: This flyer provides a high-level look at the SCDTDP and its impact nationwide.